Predicting risk of AF in ischaemic stroke using sinus rhythm ECG abnormalities: A meta-analysis.


Journal

European stroke journal
ISSN: 2396-9881
Titre abrégé: Eur Stroke J
Pays: England
ID NLM: 101688446

Informations de publication

Date de publication:
09 2023
Historique:
medline: 31 8 2023
pubmed: 29 8 2023
entrez: 29 8 2023
Statut: ppublish

Résumé

To identify ECG changes in sinus rhythm that may be used to predict subsequent development of new AF. We identified prospective and retrospective cohort or case control studies evaluating ECG patterns from a 12-lead ECG in sinus rhythm taken in hospital or community predicting subsequent development of new AF. For each identified ECG predictor, we then identify absolute event rates and pooled risk ratios (RR) using an aggregate level random effects meta-analysis. We identified 609,496 patients from 22 studies. ECG patterns included P wave terminal force V1 (PTFV1), interatrial block (IAB) and advanced interatrial block (aIAB), abnormal P wave axis (aPWA), PR prolongation and atrial premature complexes (APCs). Pooled risk ratios reached significance for each of these; PTFV1 RR 1.48 (95% CI 1.04-2.10), IAB 2.54 (95% CI 1.64-3.93), aIAB 4.05 (95% CI 2.64-6.22), aPWA 1.89 (95% CI 1.25-2.85), PR prolongation 2.22 (95% CI 1.27-3.87) and APCs 3.71 (95% CI 2.23-6.16). Diabetes reduced the predictive value of PR prolongation. APC and aIAB were most predictive of AF, while IAB, PR prolongation, PTFV1 and aPWA were also significantly associated with development of AF. These support their use in a screening tool to identify at risk cohorts who may benefit from further investigation, or following stroke, with empirical anticoagulation.

Identifiants

pubmed: 37641552
doi: 10.1177/23969873231172559
pmc: PMC10472966
doi:

Types de publication

Meta-Analysis Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

712-721

Références

Am J Cardiol. 2017 Dec 1;120(11):1980-1984
pubmed: 28941601
Ann Noninvasive Electrocardiol. 2021 Sep;26(5):e12854
pubmed: 33963655
Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1116-21
pubmed: 25381332
Circ J. 2020 Nov 25;84(12):2286-2295
pubmed: 33132228
Stroke. 2013 May;44(5):1226-31
pubmed: 23482602
JAMA. 2009 Jun 24;301(24):2571-7
pubmed: 19549974
J Cardiovasc Electrophysiol. 2015 Jan;26(1):36-41
pubmed: 25199533
Heart Rhythm. 2015 Jan;12(1):155-62
pubmed: 25267584
Int J Cardiol. 2018 Jan 1;250:152-156
pubmed: 29017777
N Engl J Med. 2018 Jun 07;378(23):2191-2201
pubmed: 29766772
Am J Cardiol. 2016 Jan 1;117(1):100-4
pubmed: 26552511
J Am Coll Cardiol. 2017 Aug 8;70(6):756-765
pubmed: 28774383
Ann Noninvasive Electrocardiol. 2020 Jul;25(4):e12739
pubmed: 32022368
J Hypertens. 2018 Sep;36(9):1874-1881
pubmed: 29677051
N Engl J Med. 2019 May 16;380(20):1906-1917
pubmed: 31091372
J Am Heart Assoc. 2018 May 30;7(11):
pubmed: 29848496
Int J Stroke. 2019 Feb;14(2):207-214
pubmed: 30196789
JAMA Neurol. 2021 Dec 1;78(12):1454-1460
pubmed: 34694346
Europace. 2019 May 1;21(5):698-707
pubmed: 30508087
Heart Lung Circ. 2019 Nov;28(11):1664-1669
pubmed: 30527848
Eur Heart J. 2015 Jan 14;36(3):170-8
pubmed: 25358506
Stroke. 2020 Jun;51(6):1758-1765
pubmed: 32404035
J Electrocardiol. 2019 May - Jun;54:22-27
pubmed: 30851473
Int J Stroke. 2016 Apr;11(3):302-12
pubmed: 26763916
Am J Cardiol. 2016 Jun 1;117(11):1755-9
pubmed: 27072646
Expert Rev Cardiovasc Ther. 2017 Aug;15(8):591-599
pubmed: 28718666
Circulation. 2014 May 27;129(21):2094-9
pubmed: 24633881
J Cardiol. 2019 Jan;73(1):65-72
pubmed: 30064946
Am J Cardiol. 2017 Feb 1;119(3):466-472
pubmed: 27889043
Sci Rep. 2023 Jan 21;13(1):1192
pubmed: 36681691
Cardiovasc Diabetol. 2020 Jan 18;19(1):9
pubmed: 31954408
J Stroke Cerebrovasc Dis. 2020 Apr;29(4):104626
pubmed: 31954605
Lancet Neurol. 2014 Apr;13(4):429-38
pubmed: 24646875
Ann Noninvasive Electrocardiol. 2020 Sep;25(5):e12751
pubmed: 32274894
Am J Cardiol. 2017 Sep 1;120(5):782-785
pubmed: 28705381
BMC Cardiovasc Disord. 2017 Jul 24;17(1):200
pubmed: 28738786
Am J Cardiol. 2007 Feb 1;99(3):390-2
pubmed: 17261404
N Engl J Med. 2014 Jun 26;370(26):2467-77
pubmed: 24963566
Int Heart J. 2016 Sep 28;57(5):580-5
pubmed: 27593538
Neurology. 2013 Apr 23;80(17):1546-50
pubmed: 23535493
Am J Cardiol. 2020 Aug 1;128:191-195
pubmed: 32650919
Europace. 2020 Aug 1;22(8):1173-1181
pubmed: 32556298
Cerebrovasc Dis. 2021;50(1):46-53
pubmed: 33311022
Neural Regen Res. 2022 May;17(5):1009-1010
pubmed: 34558523
Ann Med. 2020 May - Jun;52(3-4):63-73
pubmed: 32077319

Auteurs

Alexander Berry-Noronha (A)

Christchurch Hospital, Christchurch, New Zealand.

Luke Bonavia (L)

Royal Hobart Hospital, Hobart, TAS, Australia.

Duncan Wilson (D)

New Zealand Brain Research Institute, Christchurch, New Zealand.

Antti Eranti (A)

Heart Center, Central Hospital of North Karelia, Joensuu, Finland.

Maria Uggen Rasmussen (MU)

Department of Cardiology, Copenhagen University Hospital of Bispebjerg, Copenhagen, Denmark.

Ahmad Sajadieh (A)

Department of Cardiology, Copenhagen University Hospital of Bispebjerg, Copenhagen, Denmark.

Fabienne Kreimer (F)

Cardiology and Rhythmology, University Hospital St Josef Hospital, Ruhr University, Bochum, Germany.

Michael Gotzmann (M)

Cardiology and Rhythmology, University Hospital St Josef Hospital, Ruhr University, Bochum, Germany.

Ramesh Sahathevan (R)

Ballarat Base Hospital, Ballarat, VIC, Australia.
Department of Medicine, Deakin University, Geelong, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH